Drug discovery and development – Page 13
-
Business
What are the risks of fast-tracking a Covid-19 vaccine?
Condensing timelines from years to months inevitably involves compromises
-
Business
Scrambling and gambling to scale up Covid-19 medicines
Organisations work towards making billions of doses of products not yet proven to work
-
Opinion
Dragons of immunology
Anti-inflammatories like dexamethasone are triumphs amid the pitfalls of the immune system
-
News
Explainer: how is the vaccine pipeline for Covid-19 looking?
The race to develop a vaccine is almost six months old. Who’s in the lead?
-
Podcast
Dexamethasone
News that this cheap, ubiquitous steroid drug may reduce deaths in Covid-19 cases has been greeted with cautious optimism
-
News
Covid-19 is forcing pharma to rethink clinical trials
Drug trials have become a casualty of Covid-19, but the pandemic is also prompting change
-
Webinar
WL Gore: Optimising production processes with Design of Experiments
Learn how WL Gore use definitive screening designs to analyse multiple factors and optimise production processes
-
Feature
The difficulties of drugging our brains
Following the withdrawal of many large pharma companies from central nervous system research, Andy Extance finds new drug development patterns are emerging
-
Opinion
Collaboration is key to AI-aided drug discovery
The AI Cures project shows how artificial intelligence can assist the search for a cure for Covid-19
-
Article
Optimising biotech processes
Fujifilm Diosynth Biotechnologies achieve both speed and scale through designed experiments
-
Research
Database offers another way to search for drugs – by activity not structure
Dataset offers new way for biomedical researchers to identify potential drug candidates
-
Feature
Drugging the gut microbiome
Treating the bacteria that live inside us can improve our own health. Clare Sansom meets our tiny friends
-
Webinar
Teaching Design of Experiments to chemists: lessons from Imperial College London
First-hand experience from Imperial College London: Join us to learn about the importance and efficient implementation of a DoE training program in chemistry
-
News
Vaccine manufacturing centre to be rushed into service a year early by UK government
Injection of new funding will mean centre opens in 2021 as licensing deal also agreed to boost vaccine capabilities
-
Business
How Covid-19 is changing drug manufacturing
Catalent is adapting, focusing on employee safety and supply chain security
-
Business
This little Crispr went to market
Gene editing technology heading towards commercial reality in pharmaceuticals, food and organ transplant
-
Opinion
Alice Ball’s treatment for leprosy
Nina Notman tells the overlooked story of historic African-American chemist Alice Ball who developed the first partially-effective treatment for leprosy
-
Opinion
Hopes and fears for remdesivir
Available resources for testing coronavirus treatments need to be used wisely
-
Opinion
Does the drug work, or not?
Coronavirus trials reveal the murky reality of disentangling compounds’ effects on human biology
-
Podcast
Interferon beta
An immune-modulating compound used to reduce the symptoms of multiple sclerosis and now showing potential against coronaviruses